Lyra Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.40

-0.09 (-18.16%)

As of Mar 24, 10:15 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,391.3% upside

Low Target $9.32

Average Target $14.00

High Target $16.42

Current Price $0.40

Current
$0.40

Target
$14.00

$9.32 $14.00 avg $16.42

Scenario Analysis

Bear Case

$9.32

2,224.2%

Low target

Base Case

$14.00

+3,391.3%

Avg target

Bull Case

$16.42

+3,994.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

Target vs 52W High

$14.00

-62.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%